Wills Robert James - Insider Non-Derivative Transactions at Oncternal Therapeutics, Inc. (ONCT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Apr 8, 2024, Wills Robert James's relationship to Oncternal Therapeutics, Inc. (ONCT) is Director, and currently has 10,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ONCT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Wills Robert James - Insider Non-Derivative Transactions of ONCT Common Stock

Wills Robert James - Insider Non-Derivative Transactions at ONCT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Apr 9, 2024	P -- (Common Stock)	3086	8.96	10000
Mar 29, 2024	P -- (Common Stock)	6914	8.48	6914
Feb 24, 2024	Sell -- (Common Stock)	980	9.04	0